Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna). 2017;124(8):901–5. https://doi.org/10.1007/s00702-017-1686-y.
GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–953. https://doi.org/10.1016/S1474-4422(18)30295-3.
Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord. 2001;16(3):507–10. https://doi.org/10.1002/mds.1099.
Gulunay A, Cakmakli GY, Yon MI, Ulusoy EK, Karakoc M. Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson’s disease: a prospective descriptive case series. Psychogeriatrics. 2020;20(2):206–11. https://doi.org/10.1111/psyg.12489.
Chaudhuri JR, Mridula KR, Bandaru VCSS. Prevalence of non-motor symptoms in Parkinson’s disease: a study from South India. Turk J Neurol. 2021;27(1):52–7. https://doi.org/10.4274/tnd.2021.52993.
Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson’s disease. Neurology. 1986;36:73–5.
Magalhaes M, Wenning GK, Daniel SE, Quinn NP. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson’s disease—a retrospective comparison. Acta Neurol Scand. 1995;91:98–102.
Santamaria J, Tolosa E, Valles A. Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology. 1986;36:1130–3.
Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:235–45.
Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, et al. Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov Disord. 2012;27:617–26.
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
Forno LS. The neuropathology of Parkinson’s Disease. In: Hefti F, Weiner WJ, editors. Progress in Parkinson research. Boston: Springer; 1988. https://doi.org/10.1007/978-1-4613-0759-4_2.
Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008;15(Suppl 1):14–20. https://doi.org/10.1111/j.1468-1331.2008.02056.x.
Carroll V, Rossiter R, Blanchard D. Non-motor symptoms of Parkinson’s disease. Aust J Gen Pract. 2021;50(11):812–7. https://doi.org/10.31128/AJGP-07-21-6093.
Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004;127:773–82.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. JNNP. 1992;55:181–4.
Khalil H, Aldaajani ZF, Aldughmi M, Al-Sharman A, Mohammad T, Mehanna R, et al. Validation of the arabic version of the movement disorder society-unified Parkinson’s disease rating scale. Mov Disord. 2022;37(4):826–41. https://doi.org/10.1002/mds.28905.
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134–9. https://doi.org/10.1176/jnp.4.2.134.
Saleh AA, Alkholy RSAEHA, Khalaf OO, Sabry NA, Amer H, El-Jaafary S, et al. Validation of Montreal Cognitive Assessment-Basic in a sample of elderly Egyptians with neurocognitive disorders. Aging Ment Health. 2019;23(5):551–7. https://doi.org/10.1080/13607863.2018.1428936.
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22(16):2314–24. https://doi.org/10.1002/mds.21844.
Sharp R. The Hamilton rating scale for depression. Occup Med (Lond). 2015;65(4):340. https://doi.org/10.1093/occmed/kqv043.
Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002;73(6):629–35. https://doi.org/10.1136/jnnp.73.6.629.
Lundqvist C, Beiske AG, Reiertsen O, Kristiansen IS. Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients. J Neurol. 2014;261(12):2438–45. https://doi.org/10.1007/s00415-014-7515-4.
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641–9. https://doi.org/10.1002/mds.22643.
Li H, Zhang M, Chen L, Zhang J, Pei Z, Hu A, et al. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson’s disease. Mov Disord. 2010;25(16):2740–6. https://doi.org/10.1002/mds.23368.
Zhang H, Gu Z, An J, Wang C, Chan P. Non-motor symptoms in treated and untreated Chinese patients with early Parkinson’s disease. Tohoku J Exp Med. 2014;232(2):129–36. https://doi.org/10.1620/tjem.232.129.
Rukmini Mridula K, Borgohain R, Jabeen SA, Padmaja G, Bandaru VS, Ankathi P, et al. Comparison of frequencies of non motor symptoms in Indian Parkinson’s disease patients on medical management versus deep brain stimulation: a case-control study. Iran J Neurol. 2015;14(2):86–93.
Liu WM, Lin RJ, Yu RL, Tai CH, Lin CH, Wu RM. The impact of nonmotor symptoms on quality of life in patients with Parkinson’s disease in Taiwan. Neuropsychiatr Dis Treat. 2015;11(11):2865–73. https://doi.org/10.2147/NDT.S88968.
Ravan A, Ahmad FM, Chabria S, Gadhari M, Sankhla CS. Non-motor symptoms in an Indian cohort of Parkinson’s disease patients and correlation of progression of non-motor symptoms with motor worsening. Neurol India. 2015;63(2):166–74. https://doi.org/10.4103/0028-3886.156276.
Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in Parkinson’s disease. Lancet Neurol. 2018;17(6):559–68. https://doi.org/10.1016/S1474-4422(18)30127-3.
Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(8):509. https://doi.org/10.1038/nrn.2017.91.
Kitani-Morii F, Kasai T, Horiguchi G, Teramukai S, Ohmichi T, Shinomoto M, et al. Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan. PLoS ONE. 2021;16(1): e0245864. https://doi.org/10.1371/journal.pone.0245864.
Rizos A, Martinez-Martin P, Odin P, Antonini A, Kessel B, Kozul TK, et al. Characterizing motor and non-motor aspects of early-morning off periods in Parkinson’s disease: an international multicenter study. Parkinsonism Relat Disord. 2014;20(11):1231–5. https://doi.org/10.1016/j.parkreldis.2014.09.013.
Ragab OA, Elheneedy YA, Bahnasy WS. Non-motor symptoms in newly diagnosed Parkinson’s disease patients. Egypt J Neurol Psychiatry Neurosurg. 2019;55:24. https://doi.org/10.1186/s41983-019-0070-2.
Mele B, Merrikh D, Ismail Z, Goodarzi Z. Detecting apathy in individuals with Parkinson’s disease: a systematic review. J Parkinsons Dis. 2019;9(4):653–64. https://doi.org/10.3233/JPD-191619 (PMID: 31424418).
Robert G, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Péron J, et al. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology. 2012;79(11):1155–60. https://doi.org/10.1212/WNL.0b013e3182698c75.
Sousa M, Moreira F, Jesus-Ribeiro J, Marques I, Cunha F, Canário N, et al. Apathy profile in Parkinson’s and Huntington’s disease: a comparative cross-sectional study. Eur Neurol. 2018;79(1–2):13–20. https://doi.org/10.1159/000481981.
Shalash AS, Hamid E, Elrassas HH, Bedair AS, Abushouk AI, Khamis M, et al. Non-motor symptoms as predictors of quality of life in Egyptian patients with Parkinson’s disease: a cross-sectional study using a culturally adapted 39-item Parkinson’s disease questionnaire. Front Neurol. 2018;24(9):357. https://doi.org/10.3389/fneur.2018.00357.
Wang YQ, Tang BS, Yan XX, Chen ZH, Xu Q, Liu ZH, et al. A neurophysiological profile in Parkinson’s disease with mild cognitive impairment and dementia in China. J Clin Neurosci. 2015;22(6):981–5. https://doi.org/10.1016/j.jocn.2014.11.030.
Jones JD, Mangal P, Lafo J, Okun MS, Bowers D. Mood differences among Parkinson’s disease patients with mild cognitive impairment. J Neuropsychiatry Clin Neurosci. 2016;28(3):211–6. https://doi.org/10.1176/appi.neuropsych.15090221.
Hong JY, Lee Y, Sunwoo MK, Sohn YH, Lee PH. Subjective cognitive complaints and objective cognitive impairment in Parkinson’s disease. J Clin Neurol. 2018;14(1):16–21. https://doi.org/10.3988/jcn.2018.14.1.16.
Orfei MD, Assogna F, Pellicano C, Pontieri FE, Caltagirone C, Pierantozzi M, et al. Anosognosia for cognitive and behavioral symptoms in Parkinson’s disease with mild dementia and mild cognitive impairment: frequency and neuropsychological/neuropsychiatric correlates. Parkinsonism Relat Disord. 2018;54:62–7. https://doi.org/10.1016/j.parkreldis.2018.04.015.
Monastero R, Cicero CE, Baschi R, Davì M, Luca A, Restivo V, et al. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS). J Neurol. 2018;265(5):1050–8. https://doi.org/10.1007/s00415-018-8800-4.
Baiano C, Barone P, Trojano L, Santangelo G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson’s disease: a meta-analysis. Mov Disord. 2020;35(1):45–54. https://doi.org/10.1002/mds.27902.
Khedr EM, Abdelrahman AA, Elserogy Y. Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life. Egypt J Neurol Psychiatry Neurosurg. 2020;56:116. https://doi.org/10.1186/s41983-020-00253-5.
Veazey C, Aki SO, Cook KF, Lai EC, Kunik ME. Prevalence and treatment of depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2005;17(3):310–23. https://doi.org/10.1176/jnp.17.3.310.
Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–9. https://doi.org/10.1002/mds.21803.
Hermanowicz N, Jones SA, Hauser RA. Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey. Neuropsychiatr Dis Treat. 2019;5(15):2205–12. https://doi.org/10.2147/NDT.S213917.
Rai NK, Goyal V, Kumar N, Shukla G, Srivastava AK, Singh S, et al. Neuropsychiatric co-morbidities in non-demented Parkinson’s disease. Ann Indian Acad Neurol. 2015;18:33–8.
Gallagher DA, Goetz GC, Stebbins G, Less JA, Schrag A. Validation of MDS-UPDRS part I for nonmotor symptoms in Parkinson’s disease. Wiley Online Library. 2011;1(27):79–83.
Cui SS, Du JJ, Fu R, Lin QY, Huang P, He YC, et al. Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease. BMG Geriatr. 2017;17:1–10.
Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson’s disease. Mov Disord. 2002;17(4):775–81. https://doi.org/10.1002/mds.10167.
Batla A, Phé V, De Min L, Panicker JN. Nocturia in Parkinson’s disease: why does it occur and how to manage? Mov Disord Clin Pract. 2016;3(5):443–51. https://doi.org/10.1002/mdc3.12374.
Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, et al. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson’s disease: a multicentre cross-sectional study. J Neurol Neurosurg Psychiatry. 2017;88(11):953–9. https://doi.org/10.1136/jnnp-2017-316136.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
